Viewing Study NCT01409135


Ignite Creation Date: 2025-12-24 @ 10:16 PM
Ignite Modification Date: 2025-12-29 @ 9:24 PM
Study NCT ID: NCT01409135
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2011-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module